Get started
MEDIFAST INCMEDIFAST INCMEDIFAST INC

MEDIFAST INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MED chart


Full chart

MED upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪198.63 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
25.92
Basic EPS (TTM)
0.67 USD
Net income (FY)
‪99.42 M‬ USD
Revenue (FY)
‪1.07 B‬ USD
Shares float
‪10.61 M‬
Beta (1Y)
−0.63

Employees


Employees (FY)
634
Change (1Y)
−240 −27.46%
Revenue / Employee (1Y)
‪1.69 M‬ USD
Net income / Employee (1Y)
‪156.81 K‬ USD

About MEDIFAST INC


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Daniel R. Chard
Website
medifastinc.com
Headquarters
Baltimore
Founded
1981
FIGI
BBG000BWBW76
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MED news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where MED is featured.

See all sparks 

Frequently Asked Questions


The current price of MED is 18.16 USD — it has increased by 2.94% in the past 24 hours. Watch MEDIFAST INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange MEDIFAST INC stocks are traded under the ticker MED.
MED stock has fallen by −8.33% compared to the previous week, the month change is a −1.87% fall, over the last year MEDIFAST INC has showed a −72.98% decrease.
We've gathered analysts' opinions on MEDIFAST INC future price: according to them, MED price has a max estimate of 17.00 USD and a min estimate of 16.00 USD. Watch MED chart and read a more detailed MEDIFAST INC stock forecast: see what analysts think of MEDIFAST INC and suggest that you do with its stocks.
MED reached its all-time high on May 28, 2021 with the price of 336.99 USD, and its all-time low was 0.09 USD and was reached on Dec 23, 1999. View more price dynamics on MED chart.
See other stocks reaching their highest and lowest prices.
MED stock is 6.05% volatile and has beta coefficient of −0.63. Track MEDIFAST INC stock price on the chart and check out the list of the most volatile stocks — is MEDIFAST INC there?
Today MEDIFAST INC has the market capitalization of ‪198.63 M‬, it has decreased by −11.50% over the last week.
Yes, you can track MEDIFAST INC financials in yearly and quarterly reports right on TradingView.
MEDIFAST INC is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
MED earnings for the last quarter are 0.35 USD per share, whereas the estimation was −0.19 USD resulting in a 284.21% surprise. The estimated earnings for the next quarter are −0.16 USD per share. See more details about MEDIFAST INC earnings.
MEDIFAST INC revenue for the last quarter amounts to ‪140.16 M‬ USD, despite the estimated figure of ‪138.15 M‬ USD. In the next quarter, revenue is expected to reach ‪114.25 M‬ USD.
MED net income for the last quarter is ‪1.13 M‬ USD, while the quarter before that showed ‪−8.15 M‬ USD of net income which accounts for 113.85% change. Track more MEDIFAST INC financial stats to get the full picture.
Yes, MED dividends are paid quarterly. The last dividend per share was 1.65 USD. As of today, Dividend Yield (TTM)% is 0.00%. Tracking MEDIFAST INC dividends might help you take more informed decisions.
MEDIFAST INC dividend yield was 7.36% in 2023, and payout ratio reached 54.38%. The year before the numbers were 5.69% and 51.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 634.00 employees. See our rating of the largest employees — is MEDIFAST INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIFAST INC EBITDA is ‪25.90 M‬ USD, and current EBITDA margin is 13.44%. See more stats in MEDIFAST INC financial statements.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIFAST INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIFAST INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIFAST INC stock shows the sell signal. See more of MEDIFAST INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.